REFERENCES
- Cazzola M. Problems and prospectives in the antibiotic treatment of lower respiratory tract infections. Pulm Pharmacol 1994; 7: 139–152.
- Valcke Y, Pauwels R, Van der Straeten M. Pharmacokinetics of antibiotics in the lung. Eur Respir J 1990; 3: 715–722.
- Honeyboume D, Baldwin DR. The site concentrations of antimicrobial agents in the lung. J Antimicrob Chemother 1992; 30: 249–260.
- Baldwin DR, Honeyboume D, Wise R. Pulmonary dis-position of antimicrobial agents: methodological considera-tions relevance. Antimicrob Agents Chemother 1992; 36: 1171–1175.
- Kercsmar CM, Stern RC, Reed MD, Myers CM, Murdell D, Blumer JL. Ceftazidime in cystic fibrosis: pharma-cokinetics and therapeutic response. J Antimicrob Chemother 1983; 12 (Suppl A): 289-295.
- Ando F, Girbino G, Ferrara F. Position of ceftazidime in respiratory diseases. Drugs Exp Clin Res 1985; 11: 369–372.
- Micklefield GH, Schott D, Zimmermann I, Ulmer WI. Treatment of severe chronic bronchitis with ceftazidime. J Hosp Infect 1990; 15 (suppl A): 65-67.
- American Thoracic Society. Chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 1962; 85: 762–768.
- Baldwin DR, Wise R, Andrews JM, Honeyboume D. Concentrations of antimicrobials in pulmonary alveolar epithelial lining. Res Clin Forums 1990; 12 (4): 103–113.
- Rennard S, Basser G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as a marker of dilution. J Appl Physiol 1986; 60: 532–538.
- Wise R, Andrews JM, Bedford KA. Comparison of in vitro activity of GR 20263, a novel cephalosporin derivative, with activities of other beta-lactam compounds. Antimicrob Agents Chemother 1980; 17: 884–889.
- Langer M, Cantoni P, Bellosta C, Boccazzi A. Penetration of ceftazidime into bronchial secretions in critically ill patients. J Antimicrob Chemother 1991; 28: 925–932.
- Grassi C. Cephalosporins in lung diseases. In: Flenley DC, Petty TL, eds. Recent Advances in Respiratory Medicine. 4. Edinburgh, Churchill Livingstone, 1986; 65-75.
- Thadepalli H. Lower respiratory tract. In: Ristuccia AM, Cunha BA, eds. Antimicrobial Therapy. New York, Raven Press; 1984: 439-454.
- Bergogne-Berezin, Vallee E. Pharmacokinetics of antibiotics in respiratory tissues and fluids. In: Pennington JE, ed. Respiratory infections: diagnosis and management, 3rd ed. New York, Raven Press; 1994: 715-740.
- Fraschini F, Scaglione F. Study on the relationship between pharmacokinetics and antibacterial activity: compari-son between ceftriaxone and cefotaxime within the respirato-ry tract. Chemotherapy 1989; 35: 77–82.
- Kamnev IuV, Manuilov KK, Orlov VA. Sravnitelnaia farmakokinetika tseftriaksona v kroni i bronkhial'nom sekrete u bol'nykh s razlichnoi dlitel'nosfiu techeniia khronicheskogo bronkhita. Antibiot Khimioter 1991; 36: 48–50.
- Wise R, Baldwin DR, Honeyboume D. Penetration of antibiotics into the bronchial mucosa. Res Clin Forums 1990; 12 (4): 95–100.
- Marlin GE, Nicholls AJ, Funnell GR, Bradbury R. Penetration of cefaclor into bronchial mucosa. Thorax 1984; 39: 813–817.
- Baldwin DR, Maxwell SRJ, Honeyboume D, Andrews JM, Ashby JP, Wise R. The penetration of cefpirome into the potential sites of pulmonary infection. J Antimicrob Chemother 1991; 28: 79–86.
- Walstad RA. Concentrations of antibiotics in sputum. Res Clin Forums 1990; 12 (4): 87–92.